Published in:
01-10-2008 | Editorial
Tracheostomy timing, enrollment and power in ICU clinical trials
Authors:
Damon C. Scales, Jeremy M. Kahn
Published in:
Intensive Care Medicine
|
Issue 10/2008
Login to get access
Excerpt
Tracheostomy is provided to between 5 and 11% of patients requiring mechanical ventilation, accounting for 26% of all ventilator days and 14% of all hospital days [
1,
2]. The procedure has several theoretical advantages over continued endotracheal intubation, including the potential to improve patient comfort and communication, decrease sedation requirements, and facilitate liberation from mechanical ventilation [
3]. However, tracheostomy is not without risk. A strategy of prolonged intubation may allow for many patients to be successfully liberated from mechanical ventilation without the potential for adverse events that are associated with the procedure [
4]. These concerns result in an ongoing debate about the optimal timing of tracheostomy in the intensive care unit (ICU). Indeed, randomized trials in this area show mixed results [
5], and wide variations in practice patterns persist [
6]. …